Previous Article | Next Article 
Molecular and Cellular Biology, June 2007, p. 4444-4453, Vol. 27, No. 12
0270-7306/07/$08.00+0 doi:10.1128/MCB.02404-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Constitutively Activated Stat3 Induces Tumorigenesis and Enhances Cell Motility of Prostate Epithelial Cells through Integrin ß6
,
Janeen Azare,1
Kenneth Leslie,1
Hikmat Al-Ahmadie,2
William Gerald,2
Paul H. Weinreb,3
Shelia M. Violette,3 and
Jacqueline Bromberg1*
Departments of Medicine,1
Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021,2
Biogen Idec, Inc., Cambridge, Massachusetts 021423
Received 22 December 2006/
Returned for modification 16 February 2007/
Accepted 3 April 2007
The persistent activation of signal transducer and activator of transcription 3 (Stat3) is a common feature of prostate cancer. However, little is known about the Stat3 targets that may mediate prostate tumorigenesis. The introduction of an activating mutant form of Stat3 (Stat3-C) into immortalized prostate epithelial cells resulted in tumorigenesis. Stat3-C-expressing cells had decreased E-cadherin levels, increased numbers of lamellipodia and stress fibers, and enhanced migratory capacities compared to vector control-expressing cells, with a concomitant increase in the expression of integrin ß6 and its ligand, fibronectin (FN). Exogenously added FN increased cellular migration, with a concomitant loss of E-cadherin expression. The blockade of integrin
vß6 in Stat3-C-expressing cells inhibited migration, increased E-cadherin levels, and reduced colony formation in soft agar. These results demonstrate the sufficiency of constitutively activated Stat3 in mediating prostate tumorigenesis and identify novel Stat3 targets that are involved in promoting cell migration and transformation.
* Corresponding author. Mailing address: Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-8191. Fax: (646) 422-2231. E-mail: bromberj{at}mskcc.org
Published ahead of print on 16 April 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
Molecular and Cellular Biology, June 2007, p. 4444-4453, Vol. 27, No. 12
0270-7306/07/$08.00+0 doi:10.1128/MCB.02404-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Goel, H. L., Li, J., Kogan, S., Languino, L. R
(2008). Integrins in prostate cancer progression. Endocr Relat Cancer
15: 657-664
[Abstract]
[Full Text]
-
Cheranov, S. Y., Karpurapu, M., Wang, D., Zhang, B., Venema, R. C., Rao, G. N.
(2008). An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood
111: 5581-5591
[Abstract]
[Full Text]
-
Kida, H., Mucenski, M. L., Thitoff, A. R., Le Cras, T. D., Park, K.-S., Ikegami, M., Muller, W., Whitsett, J. A.
(2008). GP130-STAT3 Regulates Epithelial Cell Migration and Is Required for Repair of the Bronchiolar Epithelium. Am. J. Pathol.
172: 1542-1554
[Abstract]
[Full Text]
-
Snyder, M., Huang, X.-Y., Zhang, J. J.
(2008). Identification of Novel Direct Stat3 Target Genes for Control of Growth and Differentiation. J. Biol. Chem.
283: 3791-3798
[Abstract]
[Full Text]
-
Koopman Van Aarsen, L. A., Leone, D. R., Ho, S., Dolinski, B. M., McCoon, P. E., LePage, D. J., Kelly, R., Heaney, G., Rayhorn, P., Reid, C., Simon, K. J., Horan, G. S., Tao, N., Gardner, H. A., Skelly, M. M., Gown, A. M., Thomas, G. J., Weinreb, P. H., Fawell, S. E., Violette, S. M.
(2008). Antibody-Mediated Blockade of Integrin {alpha}v 6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor- Regulated Mechanism. Cancer Res.
68: 561-570
[Abstract]
[Full Text]
-
Guo, Z., Li, Y., Gong, X., Yao, C., Ma, W., Wang, D., Li, Y., Zhu, J., Zhang, M., Yang, D., Wang, J.
(2007). Edge-based scoring and searching method for identifying condition-responsive protein protein interaction sub-network. Bioinformatics
23: 2121-2128
[Abstract]
[Full Text]
Copyright © 2007 by the American Society for Microbiology. All rights reserved.